Exposure to antibiotics during pregnancy or early infancy and the risk of autoimmune disease in children: A nationwide cohort study in Korea
Open Access
- 21 August 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (8) , e1004677
Abstract
Background: Emerging evidence suggests that prenatal or early-life exposure to antibiotics may contribute to the development of autoimmune diseases in children. However, previous studies investigating this association have yielded conflicting and inconclusive results, partly due to challenges related to confounding by indication and underlying genetic or familial factors. Methods and findings: A nationwide cohort study was conducted using mother-child linked claims database of Korea’s National Health Insurance Service between 2008 and 2021. Among individuals with diagnosis of infections, children exposed to antibiotics during pregnancy or early infancy were compared to those who were not exposed. The autoimmune-related outcomes of interest were the onset of type 1 diabetes, juvenile idiopathic arthritis, inflammatory bowel disease (ulcerative colitis, Crohn’s disease), systemic lupus erythematosus, and Hashimoto’s thyroiditis. The antibiotic-exposed pregnancies were compared to unexposed pregnancies using inverse probability of treatment weighting (IPTW) methods to adjust for potential imbalances and confounding by indication. Also, sibling-matched analyses were performed to minimize bias from within-family confounders. Cox proportional hazard model was applied to assess associations, and clinically relevant subgroup analyses, including sex, subclasses and exposed timing of antibiotics were also conducted. Before IPTW, we identified 1,516,574 exposed children and 1,186,516 unexposed children for pregnancy analysis, and 1,925,585 exposed and 1,421,464 unexposed for the infancy analysis. In the pregnancy analysis within the infection-restricted population, IPTW analyses showed null association between antibiotic exposure and autoimmune diseases, including type 1 diabetes (IPTW HR 1.14, 95% CI [0.96, 1.35], p-value = 0.132), juvenile idiopathic arthritis (HR 1.02, 95% CI [0.85, 1.22], p-value = 0.830), ulcerative colitis (HR 1.02, 95% CI [0.76, 1.37], p-value = 0.895), Crohn’s disease (HR 1.16, 95% CI [0.98, 1.36], p-value = 0.076), systemic lupus erythematosus (HR 0.70, 95% CI [0.49, 1.01], p-value = 0.053), and Hashimoto’s thyroiditis (HR 1.06, 95% CI [0.91, 1.23], p-value = 0.448). In the infancy analysis within the infection-restricted population, IPTW analyses showed no substantial differences in autoimmune disease risk between exposed and non-exposed groups for type 1 diabetes (IPTW HR 1.05, 95% CI [0.88, 1.26], p-value = 0.594) and juvenile idiopathic arthritis (HR 1.11, 95% CI [0.93, 1.33], p-value = 0.253), ulcerative colitis (HR 0.95, 95% CI [0.67, 1.36], p-value = 0.776), Crohn’s disease (HR 1.07, 95% CI [0.91, 1.25], p-value = 0.403), systemic lupus erythematosus (HR 1.46, 95% CI [0.95, 2.26], p-value = 0.087), and Hashimoto’s thyroiditis (HR 1.14, 95% CI [0.97, 1.33], p-value = 0.104). These results also showed similar associations in sibling-matched analyses. Subgroup analyses showed that maternal use of cephalosporins or antibiotics during first or second trimester was associated with a small increased risk of Crohn’s disease in pregnancy analysis, while antibiotic exposure in males or during the first two months of life was associated with a modestly increased risk of autoimmune thyroiditis in infancy analysis. The primary limitations of this study include potential residual confounding due to unmeasured variables. Conclusions: In this nationwide cohort study, we found no association between early-life antibiotic exposure and the overall risk of autoimmune diseases in children. These findings underscore the importance of ensuring that antibiotic use during pregnancy and early infancy is guided by clear clinical indications and highlight the need for further research to explore subgroup-specific risks in greater detail.Keywords
Funding Information
- Health Fellowship Foundation (Health Fellowship 2023)
- National Research Foundation of Korea (No RS-2023-00208978)
- National Research Foundation of Korea (RS-2024-00405650)
This publication has 53 references indexed in Scilit:
- Antibiotic Exposure and Risk of New-Onset Inflammatory Bowel Disease: A Systematic Review and Dose-Response Meta-AnalysisClinical Gastroenterology and Hepatology, 2024
- Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019eClinicalMedicine, 2023
- Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in ChildrenJAMA Pediatrics, 2023
- The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and preventionCurrent Opinion in Immunology, 2022
- Propensity score trimming mitigates bias due to covariate measurement error in inverse probability of treatment weighted analyses: A plasmode simulationStatistics in Medicine, 2021
- Role of Microbiome and Antibiotics in Autoimmune DiseasesNutrition in Clinical Practice, 2020
- Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease AutoimmunityJAMA Pediatrics, 2017
- A Review of Antibiotic Use in PregnancyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Prevalence and predictors of anti‐infective use during pregnancyPharmacoepidemiology and Drug Safety, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009